pyrazinamide has been researched along with Leishmaniasis, Cutaneous in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyrazinamide (PZA) is a constituent of short-course tuberculosis chemotherapy." | 1.35 | The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells. ( Cynamon, MH; Green, P; Hinchman, M; Huang, L; Mendez, S; Traslavina, R; Welch, JT, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendez, S | 1 |
| Traslavina, R | 1 |
| Hinchman, M | 1 |
| Huang, L | 1 |
| Green, P | 1 |
| Cynamon, MH | 1 |
| Welch, JT | 1 |
1 other study available for pyrazinamide and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.
Topics: Animals; Antiprotozoal Agents; Antitubercular Agents; B7-1 Antigen; B7-2 Antigen; Cell Line; Cell Su | 2009 |